Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma
- PMID: 29850577
- PMCID: PMC5926519
- DOI: 10.1155/2018/8459193
Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma
Abstract
Objective: Macrophages are the dominant leukocytes in the tumor microenvironment. Accumulating evidence revealed that CD204-positive (CD204+) tumor-associated macrophages (TAMs) are associated with the aggressive behavior of various cancers; however, the clinical, pathological, and prognostic associations of CD204+ TAMs with the subtype of lung adenocarcinoma have not been reported.
Methods: Tissue microarray and immunohistochemistry were constructed from clinical stage I lung adenocarcinomas with radical surgical resection. The intratumoral density of CD204+ cells was calculated using image analysis software for analyses. Survival analyses were performed using the Kaplan-Meier method and multivariate Cox proportional hazards regression models.
Results: The intratumoral density of CD204 was correlated with T stage, nodal involvement, lymphovascular invasion, and cancer relapse after the surgery, but not with age, gender, or smoking history. The density of CD204 in non-LPD was significantly higher than that in LPD. The 5-year disease-free survival (DFS) rate of CD204 high-density group was significantly worse than that of CD204 low-density group.
Conclusions: The expression of CD204 in TAMs is associated with the aggressiveness of lung adenocarcinoma. Our results suggest that a specific immune microenvironment may be associated with the biological behavior of lung adenocarcinoma.
Figures



Similar articles
-
The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.Lung Cancer. 2018 Sep;123:127-135. doi: 10.1016/j.lungcan.2018.07.015. Epub 2018 Jul 19. Lung Cancer. 2018. PMID: 30089583
-
Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.J Thorac Oncol. 2012 Dec;7(12):1790-1797. doi: 10.1097/JTO.0b013e3182745968. J Thorac Oncol. 2012. PMID: 23154550
-
Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.J Thorac Oncol. 2010 Oct;5(10):1507-15. doi: 10.1097/JTO.0b013e3181eba692. J Thorac Oncol. 2010. PMID: 20802348
-
Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.Chest. 2012 Jul;142(1):151-158. doi: 10.1378/chest.11-2458. Chest. 2012. PMID: 22302300
-
The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer.Front Immunol. 2022 Oct 17;13:1012002. doi: 10.3389/fimmu.2022.1012002. eCollection 2022. Front Immunol. 2022. PMID: 36325338 Free PMC article. Review.
Cited by
-
Exploring scavenger receptor class F member 2 and the importance of scavenger receptor family in prediagnostic diseases.Toxicol Res. 2023 Apr 14;39(3):341-353. doi: 10.1007/s43188-023-00176-2. eCollection 2023 Jul. Toxicol Res. 2023. PMID: 37398563 Free PMC article. Review.
-
The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer.Histol Histopathol. 2022 Dec;37(12):1167-1175. doi: 10.14670/HH-18-474. Epub 2022 May 31. Histol Histopathol. 2022. PMID: 35638244 Review.
-
Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways.Int J Mol Sci. 2021 Nov 9;22(22):12118. doi: 10.3390/ijms222212118. Int J Mol Sci. 2021. PMID: 34829995 Free PMC article.
-
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.Front Immunol. 2020 Aug 4;11:1731. doi: 10.3389/fimmu.2020.01731. eCollection 2020. Front Immunol. 2020. PMID: 32849616 Free PMC article. Review.
-
Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy.Cell Biochem Biophys. 2024 Sep;82(3):1735-1750. doi: 10.1007/s12013-024-01350-5. Epub 2024 Jun 17. Cell Biochem Biophys. 2024. PMID: 38884861 Review.
References
-
- Travis W. D., Brambilla E., Noguchi M., et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proceedings of the American Thoracic Society. 2011;8(5):381–385. doi: 10.1513/pats.201107-042st. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical